Reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites

被引:13
作者
Atsmon, J
Oaknin, S
Laudon, M
Laschiner, S
Gavish, M
Dagan, Y
Zisapel, N
机构
[1] FAC LIFE SCI,DEPT NEUROBIOCHEM,TEL AVIV,ISRAEL
[2] SACKLER SCH MED,WOLFSON MED SCH,CLIN PHARMACOL UNIT,TEL AVIV,ISRAEL
[3] TEL AVIV UNIV,SLEEP DISORDERS LAB,IL-69978 TEL AVIV,ISRAEL
[4] NEURIM PHARMACEUT LTD,TEL AVIV,ISRAEL
[5] TECHNION ISRAEL INST TECHNOL,RAPPAPORT FAC MED,DEPT PHARMACOL,HAIFA,ISRAEL
[6] UNIV LA LAGUNA,DEPT BIOCHEM,TENERIFE,SPAIN
关键词
melatonin; benzodiazepine; binding; brain; tolerance;
D O I
10.1111/j.1600-079X.1996.tb00241.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent reports indicate that benzodiazepines can suppress melatonin levels and that melatonin can increase brain benzodiazepine binding. We have studied the possibility of reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites. Daily injections (3 weeks) of diazepam markedly reduced I-125-melatonin binding site density in the medulla-pons but not cortex of male rats, whereas benzodiazepine binding was not significantly affected. Melatonin, administered via the drinking water, significantly enhanced benzodiazepine (H-3-RO 15-1788) binding in the medulla-pons and slightly reduced it in the cortex, but did not affect I-125-melatonin binding. Diazepam and melatonin combination reversed the suppression by diazepam of I-125-melatonin binding in the medulla-pons and the suppression by melatonin of benzodiazepine (H-3-RO 15-1788 and H-3-flunitrazepam) binding in the cerebral cortex. These results indicate benzodiazepine-mediated suppression of brain melatonin binding sites that can be abrogated by melatonin administration.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 32 条
[1]   TESTOSTERONE AND CYPROTERONE-ACETATE MODULATE PERIPHERAL BUT NOT CENTRAL BENZODIAZEPINE RECEPTORS IN RATS [J].
AMIRI, Z ;
WEIZMAN, R ;
KATZ, Y ;
BURSTEIN, O ;
EDOUTE, Y ;
LOCHNER, A ;
GAVISH, M .
BRAIN RESEARCH, 1991, 553 (01) :155-158
[2]   MODIFICATION BY OXAZEPAM OF THE DIURNAL-VARIATIONS IN BRAIN I-125 MELATONIN BINDING-SITES IN SHAM-OPERATED AND PINEALECTOMIZED RATS [J].
ANIS, Y ;
NIR, I ;
SCHMIDT, U ;
ZISAPEL, N .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1992, 89 (03) :155-166
[3]   SUBNEURONAL FATE OF INTRACEREBROVENTRICULAR INJECTED H-3 MELATONIN [J].
ANTONTAY, F ;
FORRAY, C ;
ORTEGACORONA, BG .
JOURNAL OF PINEAL RESEARCH, 1988, 5 (02) :125-133
[4]   THE SUPRACHIASMATIC NUCLEUS OF THE GOLDEN-HAMSTER - IMMUNOHISTOCHEMICAL ANALYSIS OF CELL AND FIBER DISTRIBUTION [J].
CARD, JP ;
MOORE, RY .
NEUROSCIENCE, 1984, 13 (02) :415-431
[5]  
CASTROVIEJO DA, 1986, J PINEAL RES, V3, P101
[6]   MELATONIN AND SLEEP IN HUMANS [J].
DAWSON, D ;
ENCEL, N .
JOURNAL OF PINEAL RESEARCH, 1993, 15 (01) :1-12
[7]   PHARMACOLOGY AND FUNCTION OF MELATONIN RECEPTORS [J].
DUBOCOVICH, ML .
FASEB JOURNAL, 1988, 2 (12) :2765-2773
[8]   MELATONIN RECEPTOR DENSITY IS REGULATED IN RAT PARS TUBERALIS AND SUPRACHIASMATIC NUCLEI BY MELATONIN ITSELF [J].
GAUER, F ;
MASSONPEVET, M ;
PEVET, P .
BRAIN RESEARCH, 1993, 602 (01) :153-156
[9]   INTRACEREBROVENTRICULAR INJECTION OF NALOXONE BLOCKS MELATONIN-DEPENDENT BRAIN [H-3] FLUNITRAZEPAM BINDING [J].
GOMAR, MD ;
CASTILLO, JL ;
DELAGUILA, CM ;
FERNANDEZ, B ;
ACUNACASTROVIEJO, D .
NEUROREPORT, 1993, 4 (07) :987-990
[10]   DEPENDENCE, TOLERANCE, AND ADDICTION TO BENZODIAZEPINES - CLINICAL AND PHARMACOKINETIC CONSIDERATIONS [J].
GREENBLATT, DJ ;
SHADER, RI .
DRUG METABOLISM REVIEWS, 1978, 8 (01) :13-28